Clinuvel Pharmaceuticals Ltd
SWB:UR9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clinuvel Pharmaceuticals Ltd
SWB:UR9
|
AU |
|
F
|
Fiserv Inc
DUS:FIV
|
US |
|
S
|
Sumitomo Corp
XMUN:SUMA
|
JP |
|
I
|
Ilji Technology Co Ltd
KOSDAQ:019540
|
KR |
|
E
|
Eldorado Gold Corp
NYSE:EGO
|
CA |
|
Commerzbank AG
XETRA:CBK
|
DE |
|
A
|
Avanza Bank Holding AB
F:1JJA
|
SE |
|
Multiconsult ASA
OSE:MULTI
|
NO |
|
D
|
Deutsche Boerse AG
DUS:DB1
|
DE |
|
A
|
Axos Financial Inc
SWB:BB4
|
US |
|
Apex Resources Inc
XTSX:APX
|
CA |
|
C
|
Chocoladefabriken Lindt & Spruengli AG
DUS:LSPN
|
CH |
|
Vinci SA
PAR:DG
|
FR |
Bankruptcy Probability
Clinuvel Pharmaceuticals Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Clinuvel Pharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
398.6m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Clinuvel Pharmaceuticals Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Clinuvel Pharmaceuticals Ltd has total debt of 17.3k AUD. This includes both short-term (0 AUD) and long-term (17.3k AUD) debt.
You can find a full breakdown on its Balance Sheet.